DJIA 17,647.27 -42.59 -0.24%
NASDAQ 5,140.48 12.20 0.24%
S&P 500 2,102.21 -1.63 -0.08%
market minute promo


company name or ticker

ACADIA Pharmaceuticals: Developing Late-Stage Assets With Blockbuster Potential

XLF, UBIO: Big ETF Inflows

Commit To Buy Acadia Pharmaceuticals At $32, Earn 13.8% Using Options

Notable ETF Outflow Detected - BIB, ACAD, XLRN, ACRX

ACADIA Pharmaceuticals: If I'm Right, If I'm Wrong

ACADIA Pharmaceuticals (ACAD) Strong On High Relative Volume Today

3 Common Pitfalls Biotech Investors Need to Learn to Avoid

Here is a look at three common mistakes investors make when buying biotech stocks.

Insiders Love These 3 Biotech Stocks

These three biotech stocks have big inside ownership, which means their management has a lot of financial incentive to make the company succeed.

Andreas Halvorsen Increases Stake in Esperion Therapeutics

ACADIA Pharmaceuticals Is Poised To Outperform The IBB Moving Forward

See More Articles...